MRI-Guided Neoadjuvant Chemotherapy Could be Used in HR-/HER2+ Breast Cancer
MRI-guided treatment could be used to optimize the duration of neoadjuvant chemotherapy in hormone receptor-negative/HER2-positive breast cancer.
Source: onclive.com
Stay updated with breaking news from Phase 2 Train 3 Study . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MRI-guided treatment could be used to optimize the duration of neoadjuvant chemotherapy in hormone receptor-negative/HER2-positive breast cancer.